Literature DB >> 15829698

Metastatic retinoblastoma of the maxilla and mandible.

A Taguchi1, Y Suei, I Ogawa, K Naito, T Nagasaki, K Lee, M Fujita, K Tanimoto.   

Abstract

Metastatic retinoblastoma of the jaws is very rare. We present a 4-year-old boy with metastatic retinoblastoma that involved both the maxilla and mandible simultaneously. Enhanced CT indicated bone-destructive masses with partially non-enhanced area and enhanced margin in the right maxilla and left mandible. MRI showed well-delineated masses that were isointense on T(1) weighted images and hyperintense on T(2) weighted images. Four weeks after chemotherapy and bone marrow transplantation, the size of lesions remarkably decreased. The patient died 19 months later with extensive tumour metastases despite additional chemotherapy. In this case, the dental crypt of a permanent tooth was considered the potential target through which retinoblastoma metastasized to the jaws.

Entities:  

Mesh:

Year:  2005        PMID: 15829698     DOI: 10.1259/dmfr/51279066

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  4 in total

Review 1.  Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.

Authors:  Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Tina Vosoughi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-07-20

2.  Destruction of the craniofacial skeleton in the child caused by an orbital tumor.

Authors:  Grzegorz Goncerz; Janusz Skrzat; Małgorzata Kołodziej; Jerzy Walocha
Journal:  Childs Nerv Syst       Date:  2014-09-27       Impact factor: 1.475

Review 3.  Metastasis to the Jawbones: A review of 453 cases.

Authors:  Soussan Irani
Journal:  J Int Soc Prev Community Dent       Date:  2017-03-29

4.  Metastatic retinoblastoma of the parotid and submandibular glands: a rare case report.

Authors:  Ping Wang; Yang-Jun Li; Shao-Bo Zhang; Qi-Lin Cheng; Qiong Zhang; Li-Sha He
Journal:  BMC Ophthalmol       Date:  2017-12-02       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.